Serotonergic Feedback Control

Handbook of Behavioral Neuroscience

Volumn 21, Issue C, 2010, Pages 233-247

  Sharp, Trevor ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

5 HT autoreceptor; 5 HT1A; 5 HT1B; 5 HT2; 5 HT4; antidepressant; depression; dorsal raphe nucleus; electrophysiology

Indexed keywords

EID: 84901245702     PISSN: 15697339     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-7339(10)70081-3     Document Type: Chapter

References (134)

1. 1B receptors in the regulation of serotonin cell firing and release in the rat brain J. Neurochem. 79 2001 172 182
2. G.K. Aghajanian H.J. Haigler F.E. Bloom Lysergic acid diethylamide and serotonin: direct actions on serotonin-containing neurons in rat brain Life Sci. I 11 1972 615 622
3. K.A. Allers T. Sharp Neurochemical and anatomical identification of fast- and slow-firing neurones in the rat dorsal raphe nucleus using juxtacellular labelling methods in vivo. Neuroscience 122 2003 193 204
4. J. Amat M.V. Baratta E. Paul S.T. Bland L.R. Watkins S.F. Maier Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus Nat. Neurosci. 8 2005 365 371
5. J. Amat P.D. Sparks P. Matus-Amat J. Griggs L.R. Watkins S.F. Maier The role of the habenular complex in the elevation of dorsal raphe nucleus serotonin and the changes in the behavioral responses produced by uncontrollable stress Brain Res. 917 2001 118 126
6. F. Artigas A. Adell P. Celada Pindolol augmentation of antidepressant response Curr. Drug Targets 7 2006 139 147
7. E. Audero E. Coppi B. Mlinar T. Rossetti A. Caprioli M.A. Banchaabouchi R. Corradetti C. Gross Sporadic autonomic dysregulation and death associated with excessive serotonin autoinhibition Science 321 2008 130 133
8. S. Aznar Z. Qian R. Shah B. Rahbek G.M. Knudsen The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain Brain Res. 959 2003 58 67
9. J. Ballesteros L.F. Callado Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials J. Affect. Disord. 79 2004 137 147
10. N.M. Barnes T. Sharp A review of central 5-HT receptors and their function Neuropharmacology 38 1999 1083 1152
11. B. Bjorvatn C.A. Fornal F.J. Martin C.W. Metzler B.L. Jacobs Venlafaxine and its interaction with WAY 100635: effects on serotonergic unit activity and behavior in cats Eur. J. Pharmacol. 404 2000 121 132
12. P. Blier C. Bouchard Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs Br. J. Pharmacol. 113 1994 485 495
13. P. Blier C. De Montigny Y. Chaput Electrophysiological assessment of the effects of antidepressant treatments on the efficacy of 5-HT neurotransmission Clin. Neuropharmacol. 11 Suppl. 2 1988 S1 S10
14. L.J. Boothman K.A. Allers K. Rasmussen T. Sharp Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat Br. J. Pharmacol. 139 2003 998 1004
15. L.J. Boothman S.N. Mitchell T. Sharp Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis Neuropharmacology 50 2006 726 732
16. L. Boothman J. Raley F. Denk E. Hirani T. Sharp In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism Br. J. Pharmacol. 149 2006 861 869
17. L.J. Boothman T. Sharp A role for midbrain raphe gamma aminobutyric acid neurons in 5-hydroxytryptamine feedback control Neuroreport 16 2005 891 896
18. 2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex Naunyn Schmiedebergs Arch. Pharmacol. 352 1995 283 290
19. M. Buhlen K. Fink C. Boing M. Gothert Evidence for presynaptic location of inhibitory 5-HT1D betalike autoreceptors in the guinea-pig brain cortex Naunyn Schmiedebergs Arch. Pharmacol. 353 1996 281 289
20. R.J. Carey J.P. Huston C.P. Muller Pharmacological inhibition of dopamine and serotonin activity blocks spontaneous and cocaine-activated behaviour Prog. Brain Res. 172 2008 347 360
21. J.M. Casanovas I. Hervas F. Artigas Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex Neuroreport 10 1999 1441 1445
22. M.E. Castro P.J. Harrison A. Pazos T. Sharp Affinity of (+/−)-pindolol, (−)-penbutolol, and (−)-tertatolol for pre- and postsynaptic serotonin 5-HT(1A) receptors in human and rat brain J. Neurochem. 75 2000 755 762
23. E. Castro R.M. Tordera Z.A. Hughes Q. Pei T. Sharp Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration J. Neurochem. 85 2003 1480 1487
24. A. Ceci A. Baschirotto F. Borsini The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex Neuropharmacology 33 1994 709 713
25. P. Celada M.V. Puig J.M. Casanovas G. Guillazo F. Artigas Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors J. Neurosci. 21 2001 9917 9929
26. E.M. Clifford S.E. Gartside V. Umbers P.J. Cowen M. Hajós T. Sharp Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo. Br. J. Pharmacol. 124 1998 206 212
27. G. Conductier N. Dusticier G. Lucas F. Cote G. Debonnel A. Daszuta A. Dumuis A. Nieoullon R. Hen J. Bockaert V. Compan Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knockout mouse Eur. J. Neurosci. 24 2006 1053 1062
28. 2A receptor in the central nervous system of adult rat J. Comp. Neurol. 409 1999 187 209
29. R. Corradetti A.M. Pugliese E. Le Poul N. Laaris M. Hamon L. Lanfumey Electrophysiological effects of WAY 100635, a new 5-HT1A receptor antagonist, on dorsal raphe nucleus serotoninergic neurones and CA1 pyramidal cells in vitro. Acta Physiol. Hung 84 1996 407 409
30. P.J. Cowen Serotonin and depression: pathophysiological mechanism or marketing myth? Trends Pharmacol. Sci. 29 2008 433 436
31. R. Craven D. Grahame-Smith N. Newberry WAY-100635 and GR127935: effects on 5-hydroxytryptamine-containing neurones Eur. J. Pharmacol. 271 1994 R1 R3
32. T.I. Cremers M. Giorgetti F.J. Bosker S. Hogg J. Arnt A. Mork G. Honig K.P. Bogeso B.H. Westerink H. Den Boer H.V. Wikstrom L.H. Tecott Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade Neuropsychopharmacology 29 2004 1782 1789
33. J.F. Cryan C. Mcgrath B.E. Leonard T.R. Norman Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat Pharmacol. Biochem. Behav. 63 1999 333 338
34. M. Darmon X. Langlois L. Suffisseau C.M. Fattaccini M. Hamon Differential membrane targeting and pharmacological characterization of chimeras of rat serotonin 5-HT1A and 5-HT1B receptors expressed in epithelial LLC-PK1 cells J. Neurochem. 71 1998 2294 2303
35. L.A. Dawson H.Q. Nguyen The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/−)pindolol Neuropharmacology 39 2000 1044 1052
36. S.F. De Boer J.M. Koolhaas 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis Eur. J. Pharmacol. 526 2005 125 139
37. J. De Vry 5-HT1A receptor agonists: recent developments and controversial issues Psychopharmacology (Berl.) 121 1995 1 26
38. E. Doucet M. Pohl C.M. Fattaccini J. Adrien S.E. Mestikawy M. Hamon In situ hybridization evidence for the synthesis of 5-HT1B receptor in serotoninergic neurons of anterior raphe nuclei in the rat brain Synapse 19 1995 18 28
39. M.S. Duxon K.R. Starr N. Upton Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT(1A) receptor antagonist WAY100635 Br. J. Pharmacol. 130 2000 1713 1719
40. G. Engel M. Gothert D. Hoyer E. Schlicker K. Hillenbrand Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites Naunyn Schmiedebergs Arch. Pharmacol. 332 1986 1 7
41. A. Evrard A.M. Laporte M. Chastanet R. Hen M. Hamon J. Adrien 5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knockout mice Eur. J. Neurosci. 11 1999 3823 3831
42. E. Fakra L.W. Hyde A. Gorka P.M. Fisher K.E. Munoz M. Kimak I. Halder R.E. Ferrell S.B. Manuck A.R. Hariri Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety Arch. Gen. Psychiatry 66 2009 33 40
43. L.O. Farnebo B. Hamberger Drug-induced changes in the release of 3 H-monoamines from field stimulated rat brain slices Acta Physiol. Scand. Suppl. 371 1971 35 44
44. G. Ferraro M.E. Montalbano P. Sardo V. La Grutta Lateral habenular influence on dorsal raphe neurons Brain Res. Bull. 41 1996 47 52
45. P.M. Fisher C.C. Meltzer S.K. Ziolko J.C. Price E.L. Moses-Kolko S.L. Berga A.R. Hariri Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity Nat. Neurosci. 9 2006 1362 1363
46. C.A. Fornal F. Marrosu C.W. Metzler K. Tada B.L. Jacobs Effects of the putative 5-hydroxytryptamine1A antagonists BMY 7378, NAN 190 and (−)-propranolol on serotonergic dorsal raphe unit activity in behaving cats J. Pharmacol. Exp. Ther. 270 1994 1359 1366
47. C.A. Fornal C.W. Metzler R.A. Gallegos S.C. Veasey A.C. Mccreary B.L. Jacobs WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135 J. Pharmacol. Exp. Ther. 278 1996 752 762
48. A.M. Galzin M.F. Poirier A. Lista J.P. Chodkiewicz P. Blier R. Ramdine H. Loo F.X. Roux A. Redondo S.Z. Langer Characterization of the 5-hydroxytryptamine receptor modulating the release of 5-[3H]hydroxytryptamine in slices of the human neocortex J. Neurochem. 59 1992 1293 1301
49. A.M. Gardier D.J. David G. Jego C. Przybylski C. Jacquot S. Durier B. Gruwez E. Douvier P. Beauverie N. Poisson R. Hen M. Bourin Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice J. Neurochem. 86 2003 13 24
50. S.E. Gartside V. Umbers M. Hajós T. Sharp Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT Br. J. Pharmacol. 115 1995 1064 1070
51. J. Ge N.M. Barnes 5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo. Br. J. Pharmacol. 117 1996 1475 1480
52. A. Ghavami K.L. Stark M. Jareb S. Ramboz L. Segu R. Hen Differential addressing of 5-HT1A and 5-HT1B receptors in epithelial cells and neurons J. Cell Sci. 112 Pt6 1999 967 976
53. A. Gobert J.M. Rivet L. Cistarelli M.J. Millan Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935; J Neurochem. 68 1997 1159 1163
54. M. Gothert G. Weinheimer Extracellular 5-hydroxytryptamine inhibits 5-hydroxytryptamine release from rat brain cortex slices Naunyn Schmiedebergs Arch. Pharmacol. 310 1979 93 96
55. C. Gross X. Zhuang K. Stark S. Ramboz R. Oosting L. Kirby L. Santarelli S. Beck R. Hen Serotonin1A receptor acts during development to establish normal anxietylike behaviour in the adult Nature 416 2002 396 400
56. J.P. Guilloux D.J. David B.P. Guiard F. Chenu C. Reperant M. Toth M. Bourin A.M. Gardier Blockade of 5-HT1A receptors by (+/−)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice Neuropsychopharmacology 31 2006 2162 2172
57. N. Haddjeri N. Lavoie P. Blier Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus Neuropsychopharmacology 29 2004 1800 1806
58. H.J. Haigler G.K. Aghajanian Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurons and neurons receiving a serotonergic input J. Pharmacol. Exp. Ther. 188 1974 688 699
59. M. Hajós E. Hajós-Korcsok T. Sharp Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat Br. J. Pharmacol. 126 1999 1741 1750
60. M. Hajós W.E. Hoffmann I.V. Tetko B. Hyland T. Sharp A.E. Villa Different tonic regulation of neuronal activity in the rat dorsal raphe and medial prefrontal cortex via 5-HT(1A) receptors Neurosci. Lett. 304 2001 129 132
61. M. Hajós C.D. Richards A.D. Szekely T. Sharp An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat Neuroscience 87 1998 95 108
62. T. Heinrich H. Bottcher K. Schiemann G. Holzemann M. Schwarz G.D. Bartoszyk C. Van Amsterdam H.E. Greiner C.A. Seyfried Dual 5-HT1A agonists and 5-HT reuptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity Bioorg. Med. Chem. 12 2004 4843 4852
63. F. Herold A. Chodkowski L. Izbicki M. Krol J. Kleps J. Turlo G. Nowak K. Stachowicz M. Dybala A. Siwek Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity, part 1 Eur. J. Med. Chem. 44 2009 1710 1717
64. S. Hjorth R. Tao The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969 Eur. J. Pharmacol. 209 1991 249 252
65. G.A. Hornby G. Stack L.A. Dawson H. Nguyen T. Spangler D.L. Smith H. Mazandarani M. Tran S. Kalgaonkar G. Zhang L. Schechter T. Andree SSRI/5-HT1A antagonists as future antidepressant agents: a neurochemical assessment of WAY-426 Soc. Neurosci. Abstr. 1024 2004 14
66. Z.A. Hughes K.R. Starr C.J. Langmead M. Hill G.D. Bartoszyk J.J. Hagan D.N. Middlemiss L.A. Dawson Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone Eur. J. Pharmacol. 510 2005 49 57
67. Z.A. Hughes K.R. Starr C.M. Scott M.J. Newson T. Sharp J.M. Watson J.J. Hagan L.A. Dawson Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B Psychopharmacology (Berl.) 192 2007 121 133
68. R.B. Innis E.J. Nestler G.K. Aghajanian Evidence for G protein mediation of serotonin- and GABAB-induced hyperpolarization of rat dorsal raphe neurons Brain Res. 459 1988 27 36
69. R. Invernizzi C. Velasco M. Bramante A. Longo R. Samanin Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus Neuropharmacology 36 1997 467 473
70. M.P. Jankowski S.R. Sesack Prefrontal cortical projections to the rat dorsal raphe nucleus: ultrastructural features and associations with serotonin and gamma-aminobutyric acid neurons J. Comp. Neurol. 468 2004 518 529
71. H.K. Kia M.C. Miquel M.J. Brisorgueil G. Daval M. Riad S. El Mestikawy M. Hamon D. Verge Immunocytochemical localization of serotonin1A receptors in the rat central nervous system J. Comp. Neurol. 365 1996 289 305
72. D.A. Knobelman R. Hen J.A. Blendy I. Lucki Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse J. Pharmacol. Exp. Ther. 298 2001 1092 1100
73. D.A. Knobelman H.F. Kung I. Lucki Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors J. Pharmacol. Exp. Ther. 292 2000 1111 1117
74. L. Lanfumey S. Haj-Dahmane M. Hamon Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525 Eur. J. Pharmacol. 249 1993 25 35
75. L. Lanfumey M.C. Pardon N. Laaris C. Joubert N. Hanoun M. Hamon C. Cohen-Salmon 5-HT1A autoreceptor desensitization by chronic ultramild stress in mice Neuroreport 10 1999 3369 3374
76. K.P. Lesch L. Gutknecht Focus on the 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics Intl. J. Neuropsychopharmacol. 7 2004 381 385
77. N. Limberger R. Deicher K. Starke Species differences in presynaptic serotonin autoreceptors: mainly 5-HT1B but possibly in addition 5-HT1D in the rat, 5-HT1D in the rabbit and guinea-pig brain cortex Naunyn Schmiedebergs Arch. Pharmacol. 343 1991 353 364
78. R. Liu T. Jolas G. Aghajanian Serotonin 5-HT(2) receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus Brain Res. 873 2000 34 45
79. G. Lucas V. Compan Y. Charnay R.L. Neve E.J. Nestler J. Bockaert M. Barrot G. Debonnel Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5-HT4 agonists Biol. Psychiatry 57 2005 918 925
80. G. Lucas G. Debonnel 5-HT4 receptors exert a frequency-related facilitatory control on dorsal raphe nucleus 5-HT neuronal activity Eur. J. Neurosci. 16 2002 817 822
81. G. Lucas V.V. Rymar J. Du O. Mnie-Filali C. Bisgaard S. Manta L. Lambas-Senas O. Wiborg N. Haddjeri G. Piñeyro A.F. Sadikot G. Debonnel Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action Neuron 55 2007 712 725
82. G.J. Marek L.L. Carpenter C.J. Mcdougle L.H. Price Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders Neuropsychopharmacology 28 2003 402 412
83. R. Martín-Ruiz M.V. Puig P. Celada D.A. Shapiro B.L. Roth G. Mengod F. Artigas Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism J. Neurosci. 21 2001 9856 9866
84. R. Martín-Ruiz L. Ugedo Electrophysiological evidence for postsynaptic 5-HT(1A) receptor control of dorsal raphe 5-HT neurones Neuropharmacology 41 2001 72 78
85. G. Maura S. Thellung G.C. Andrioli A. Ruelle M. Raiteri Release-regulating serotonin 5-HT1D autoreceptors in human cerebral cortex J. Neurochem. 60 1993 1179 1182
86. D.N. Middlemiss Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol Eur. J. Pharmacol. 101 1984 289 293
87. D.N. Middlemiss P.H. Hutson The 5-HT1B receptors Ann. NY Acad. Sci. 600 1990 132 147 discussion 347-18
88. M.J. Millan Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs Neurotherapeutics 6 2009 53 77
89. M.C. Miquel E. Doucet M. Riad J. Adrien D. Verge M. Hamon Effect of the selective lesion of serotoninergic neurons on the regional distribution of 5-HT1A receptor mRNA in the rat brain Brain Res. Mol. Brain Res. 14 1992 357 362
90. A. Mørk S. Hogg In vivo profile of Lu 36-274: a compound with combined 5-HTT/5-HT1A activity and putative fast onset of antidepressant action Soc. Neurosci. 2003 Abstr.: 958.17
91. I. Muraki T. Inoue T. Koyama Effect of co-administration of the selective 5-HT1A receptor antagonist WAY 100,635 and selective 5-HT1B/1D receptor antagonist GR 127,935 on anxiolytic effect of citalopram in conditioned fear stress in the rat Eur. J. Pharmacol. 586 2008 171 178
92. M.E. Newman G. Shalom A. Ran E. Gur L.D. Van De Kar Chronic fluoxetine-induced desensitization of 5-HT1A and 5-HT1B autoreceptors: regional differences and effects of WAY-100635 Eur. J. Pharmacol. 486 2004 25 30
93. A. Pazos R. Cortes J.M. Palacios Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors Brain Res. 346 1985 231 249
94. G. Piñeyro N. Castanon R. Hen P. Blier Regulation of [3H]5-HT release in raphe, frontal cortex and hippocampus of 5-HT1B knockout mice Neuroreport 7 1995 353 359
95. G. Piñeyro C. De Montigny P. Blier 5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies Neuropsychopharmacology 13 1995 249 260
96. M. Pompeiano J.M. Palacios G. Mengod Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors Brain Res. Mol. Brain Res. 23 1994 163 178
97. P. Quérée S. Peters T. Sharp Further pharmacological characterisation of 5-HT2C receptor agonist-induced inhibition of 5 HT neuronal activity in the dorsal raphe nucleus in vivo. Br. J. Pharmacol. 2009 in press.
98. P. Quérée T. Sharp Electrophysiological evidence for 5-HT2C receptor-mediated control of 5-HT cell firing in the anaesthetised rat. Proceedings of the British Pharmacological Society available online at: http://www.pA2online.org/abstracts/Vol4Issue2abst050P 2006
99. E.A. Rabiner R.N. Gunn M.E. Castro P.A. Sargent P.J. Cowen M.J. Koepp J.H. Meyer C.J. Bench P.J. Harrison A. Pazos T. Sharp P.M. Grasby beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy Neuropsychopharmacology 23 2000 285 293
100. F. Radja G. Daval M. Hamon D. Verge Pharmacological and physicochemical properties of pre-versus postsynaptic 5-hydroxytryptamine1A receptor binding sites in the rat brain: a quantitative autoradiographic study J. Neurochem. 58 1992 1338 1346
101. J. Raley L. Boothman T. Sharp Immunohistochemical evidence that 5-HT1A and 5-HT2 receptor agonists activate GABA neurones in the dorsal raphe nucleus. Proceedings of the British Pharmacological Society available online at: http://www.pA2online.org/Vol2Issue4abst066P 2004
102. H. Rollema T. Clarke J.S. Sprouse D.W. Schulz Combined administration of a 5-hydroxytryptamine (5-HT)1D antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo. J. Neurochem. 67 1996 2204 2207
103. L. Romero P. Celada F. Artigas Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/G(o) proteins in dorsal raphe nucleus Eur. J. Pharmacol. 265 1994 103 106
104. L. Romero P. Celada R. Martín-Ruiz L. Díaz-Mataix M. Mourelle J. Delgadillo I. Hervas F. Artigas Modulation of serotonergic function in rat brain by VN2222, a serotonin reuptake inhibitor and 5-HT1A receptor agonist Neuropsychopharmacology 28 2003 445 456
105. S. Rutz C. Riegert A.K. Rothmaier M.C. Buhot J.C. Cassel R. Jackisch Presynaptic serotonergic modulation of 5-HT and acetylcholine release in the hippocampus and the cortex of 5-HT1B-receptor knockout mice Brain Res. Bull. 70 2006 81 93
106. N. Santana A. Bortolozzi J. Serrats G. Mengod F. Artigas Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex Cereb. Cortex. 14 2004 1100 1109
107. Y. Sari Serotonin1B receptors: from protein to physiological function and behavior Neurosci. Biobehav. Rev. 28 2004 565 582
108. L.E. Schechter Q. Lin D.L. Smith G. Zhang Q. Shan B. Platt M.R. Brandt L.A. Dawson D. Cole R. Bernotas A. Robichaud S. Rosenzweig-Lipson C.E. Beyer Neuropharmacological profile of novel and selective 5-HT(6) receptor agonists: WAY-181187 and WAY-208466 Neuropsychopharmacology 33 2008 1323 1335
109. E. Schlicker K. Fink G.J. Molderings G.W. Price M. Duckworth L. Gaster D.N. Middlemiss J. Zentner J. Likungu M. Gothert Effects of selective h5-1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors Naunyn Schmiedebergs Arch. Pharmacol. 356 1997 321 327
110. R. Segrave P.J. Nathan Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression Hum. Psychopharmacol. 20 2005 163 174
111. J. Serrats G. Mengod R. Cortes Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei J. Chem. Neuroanat. 29 2005 83 91
112. T. Sharp S.R. Bramwell D.G. Grahame-Smith 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis Br. J. Pharmacol. 96 1989 283 290
113. T. Sharp S.R. Bramwell S. Hjorth D.G. Grahame-Smith Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis Br. J. Pharmacol. 98 1989 989 997
114. T. Sharp S. Hjorth Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor J. Neurosci. Methods 34 1990 83 90
115. T. Sharp V. Umbers S. Hjorth The role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release – II NAN-190 and SDZ 216-525 Neuropharmacology 35 1996 735 741
116. T. Sharp V. Umbers S.E. Gartside Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Br. J. Pharmacol. 121 1997 941 946
117. C. Sotelo B. Cholley S. El Mestikawy H. Gozlan M. Hamon Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei Eur. J. Neurosci. 2 1990 1144 1154
118. J.S. Sprouse G.K. Aghajanian Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons Neuropharmacology 27 1988 707 715
119. J.A. Stamford C. Davidson D.P. Mclaughlin S.E. Hopwood Control of dorsal raphe 5-HT function by multiple 5-HT(1) autoreceptors: parallel purposes or pointless plurality? Trends Neurosci. 23 2000 459 465
120. K.R. Starr G.W. Price J.M. Watson P.J. Atkinson R. Arban S. Melotto L.A. Dawson J.J. Hagan N. Upton M.S. Duxon SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test Neuropsychopharmacology 32 2007 2163 2172
121. G.M. Sullivan R.T. Ogden M.A. Oquendo J.S. Kumar N. Simpson Y.Y. Huang J.J. Mann R.V. Parsey Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression Biol. Psychiatry 2009 in press.
122. M.T. Taber J.R. Torrente J. Palmer M.A. Poss D.R. Tortolandi Y.P. Yevich A.D. Stark R.J. Mattson Pharmacological characterisation of BMS-196859, a novel serotonin uptake inhibitor and serotonin 5-HT1A receptor antagonist Soc. Neurosci. 2003 Abstr.: 958.15
123. D.R. Thomas E.M. Soffin C. Roberts J.N. Kew R.M. de la Flor L.A. Dawson V.A. Fry S.A. Coggon S. Faedo P.D. Hayes D.F. Corbett C.H. Davies J.J. Hagan SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4′-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl] propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain Neuropharmacology 51 2006 566 577
124. R. Tordera Q. Pei M. Newson K. Gray M. Sprakes T. Sharp Effect of different 5-HT1A receptor antagonists in combination with paroxetine on expression of the immediate-early gene Arc in rat brain Neuropharmacology 44 2003 893 902
125. A.C. Trillat I. Malagie K. Scearce D. Pons M.C. Anmella C. Jacquot R. Hen A.M. Gardier Regulation of serotonin release in the frontal cortex and ventral hippocampus of homozygous mice lacking 5-HT1B receptors:)n vivo microdialysis studies J. Neurochem. 69 1997 2019 2025
126. V. Varga B. Kocsis T. Sharp Electrophysiological evidence for convergence of inputs from the medial prefrontal cortex and lateral habenula on single neurons in the dorsal raphe nucleus Eur. J. Neurosci. 17 2003 280 286
127. V. Varga A.D. Szekely A. Csillag T. Sharp M. Hajós Evidence for a role of GABA interneurones in the cortical modulation of midbrain 5-hydroxytryptamine neurones Neuroscience 106 2001 783 792
128. D. Verge G. Daval M. Marcinkiewicz A. Patey S. El Mestikawy H. Gozlan M. Hamon Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats J. Neurosci. 6 1986 3474 3482
129. M.T. Vilaro R. Cortes C. Gerald T.A. Branchek J.M. Palacios G. Mengod Localization of 5-HT4 receptor mRNA in rat brain by in situ hybridization histochemistry Brain Res. Mol. Brain Res. 43 1996 356 360
130. C. Waeber M. Sebben A. Nieoullon J. Bockaert A. Dumuis Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain Neuropharmacology 33 1994 527 541
131. N.V. Weisstaub M. Zhou A. Lira E. Lambe J. Gonzalez-Maeso J.P. Hornung E. Sibille M. Underwood S. Itohara W.T. Dauer M.S. Ansorge E. Morelli J.J. Mann M. Toth G. Aghajanian S.C. Sealfon R. Hen J.A. Gingrich Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice Science 313 2006 536 540
132. R. Whale T. Terao P. Cowen N. Freemantle J. Geddes Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review J. Psychopharmacol. 2008 in press
133. I.K. Wright J.C. Garratt C.A. Marsden Effects of a selective 5-HT2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphe nucleus and 5-HT release and metabolism in the frontal cortex Br. J. Pharmacol. 99 1990 221 222
134. M. He E. Sibille D. Benjamin M. Toth T. Shippenberg Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis Brain Res. 902 2001 11 17